BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16343827)

  • 1. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.
    Vidal C; Brincat M; Xuereb Anastasi A
    Maturitas; 2006 Mar; 53(4):386-95. PubMed ID: 16343827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].
    Cheng Q; Zhu HM; Miao YX; Zhu XY; Chen XP; Zhang XM
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):274-7. PubMed ID: 15059506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.
    Yamada Y; Ando F; Niino N; Shimokata H
    Mol Genet Metab; 2003 Nov; 80(3):344-9. PubMed ID: 14680982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
    Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
    Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the impact of candidate genes on bone mineral density in postmenopausal women].
    Zhao HY; Liu JM; Ning G; Zhang LZ; Song HD; Chen Y; Jiang L; Dai M; Xu MY; Chen JL
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):803-7. PubMed ID: 16412323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
    Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
    Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
    Firat SC; Cetin Z; Samanci N; Aydin F; Balci N; Gungor F; Firat MZ; Luleci G; Karauzum SB
    Maturitas; 2009 Aug; 63(4):352-6. PubMed ID: 19520527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
    Mencej-Bedrač S; Preželj J; Marc J
    Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women.
    Rojano-Mejía D; Coral-Vázquez RM; Espinosa LC; Romero-Hidalgo S; López-Medina G; García Mdel C; Coronel A; Ibarra R; Canto P
    Maturitas; 2012 Jan; 71(1):49-54. PubMed ID: 22079369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of estrogen receptor beta gene polymorphisms with spinal bone mineral density in peri- and post-menopausal Greek women.
    Efstathiadou Z; Koukoulis G; Stakias N; Challa A; Zintzaras E; Tsatsoulis A
    Maturitas; 2006 Mar; 53(4):380-5. PubMed ID: 16125346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Am J Obstet Gynecol; 2005 Apr; 192(4):1087-93. PubMed ID: 15846185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women.
    Mencej S; Prezelj J; Kocijancic A; Ostanek B; Marc J
    Maturitas; 2006 Oct; 55(3):219-26. PubMed ID: 16730419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
    García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
    Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population.
    Wynne F; Drummond F; O'Sullivan K; Daly M; Shanahan F; Molloy MG; Quane KA
    Calcif Tissue Int; 2002 Jul; 71(1):26-35. PubMed ID: 12073153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis.
    Ohmori H; Makita Y; Funamizu M; Hirooka K; Hosoi T; Orimo H; Suzuki T; Ikari K; Nakajima T; Inoue I; Hata A
    J Hum Genet; 2002; 47(8):400-6. PubMed ID: 12181640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
    Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
    J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women.
    Zhao HY; Liu JM; Ning G; Zhao YJ; Zhang LZ; Sun LH; Xu MY; Uitterlinden AG; Chen JL
    Osteoporos Int; 2005 Dec; 16(12):1519-24. PubMed ID: 15782282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
    Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
    Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.